Compounds > succinobucol
Page last updated: 2024-09-05

succinobucol and pioglitazone

succinobucol has been researched along with pioglitazone in 1 studies

Compound Research Comparison

Studies
(succinobucol)		Trials
(succinobucol)		Recent Studies (post-2010)
(succinobucol)		Studies
(pioglitazone)		Trials
(pioglitazone)		Recent Studies (post-2010) (pioglitazone)
535164,3388242,277

Protein Interaction Comparison

ProteinTaxonomysuccinobucol (IC50)pioglitazone (IC50)
CDGSH iron-sulfur domain-containing protein 1Rattus norvegicus (Norway rat)1
Bile salt export pumpRattus norvegicus (Norway rat)2
Peroxisome proliferator-activated receptor gammaRattus norvegicus (Norway rat)0.7
Bile salt export pumpHomo sapiens (human)0.337
Carbonic anhydrase 2Homo sapiens (human)0.114
Steryl-sulfataseHomo sapiens (human)0.8
Peroxisome proliferator-activated receptor alphaMus musculus (house mouse)1.15
Amine oxidase [flavin-containing] BHomo sapiens (human)0.298
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)3.0379
Peroxisome proliferator-activated receptor gammaMus musculus (house mouse)0.7
CDGSH iron-sulfur domain-containing protein 2Homo sapiens (human)4.8
CDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)8.65

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Douglas, JS1

Reviews

1 review(s) available for succinobucol and pioglitazone

ArticleYear
Pharmacologic approaches to restenosis prevention.
    The American journal of cardiology, 2007, Sep-03, Volume: 100, Issue:5A

    Topics: Angioplasty, Balloon, Coronary; Cilostazol; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Humans; ortho-Aminobenzoates; Pioglitazone; Platelet Aggregation Inhibitors; Probucol; Risk Factors; Stents; Tetrazoles; Thiazolidinediones; Trapidil; Treatment Outcome

2007